ARTVArtiva Biotherapeutics, Inc.

$6.13+37% 1Y

Is the price fair?

What ARTV's price assumes

Price / book
1.10

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
1.10
Market capitalisation48.9 million shares, counted Jul 31, 2026
$300M

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.